These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 10947858)
21. Recombinant live vaccine candidates against tuberculosis. Kaufmann SH; Gengenbacher M Curr Opin Biotechnol; 2012 Dec; 23(6):900-7. PubMed ID: 22483201 [TBL] [Abstract][Full Text] [Related]
22. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains]. Prygiel M; Janaszek-Seydlitz W; Bucholc B Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050 [TBL] [Abstract][Full Text] [Related]
23. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations. Whelan AO; Wright DC; Chambers MA; Singh M; Hewinson RG; Vordermeier HM Vaccine; 2008 Jan; 26(2):166-73. PubMed ID: 18055073 [TBL] [Abstract][Full Text] [Related]
24. Live tuberculosis vaccines based on phoP mutants: a step towards clinical trials. Asensio JA; Arbués A; Pérez E; Gicquel B; Martin C Expert Opin Biol Ther; 2008 Feb; 8(2):201-11. PubMed ID: 18194076 [TBL] [Abstract][Full Text] [Related]
25. Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guérin in long-term murine infection. Sherman DR; Guinn KM; Hickey MJ; Mathur SK; Zakel KL; Smith S J Infect Dis; 2004 Jul; 190(1):123-6. PubMed ID: 15195251 [TBL] [Abstract][Full Text] [Related]
28. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250 [TBL] [Abstract][Full Text] [Related]
29. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice. Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812 [TBL] [Abstract][Full Text] [Related]
31. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Horwitz MA; Harth G; Dillon BJ; Maslesa-Galic' S Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13853-8. PubMed ID: 11095745 [TBL] [Abstract][Full Text] [Related]
32. Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines. Scriba TJ; Kaufmann SH; Henri Lambert P; Sanicas M; Martin C; Neyrolles O J Infect Dis; 2016 Sep; 214(5):659-64. PubMed ID: 27247343 [TBL] [Abstract][Full Text] [Related]
33. New vaccines for the prevention of tuberculosis. von Reyn CF; Vuola JM Clin Infect Dis; 2002 Aug; 35(4):465-74. PubMed ID: 12145732 [TBL] [Abstract][Full Text] [Related]
34. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Behr MA; Wilson MA; Gill WP; Salamon H; Schoolnik GK; Rane S; Small PM Science; 1999 May; 284(5419):1520-3. PubMed ID: 10348738 [TBL] [Abstract][Full Text] [Related]
35. Recombinant BCG as a vaccine vehicle to protect against tuberculosis. Triccas JA Bioeng Bugs; 2010; 1(2):110-5. PubMed ID: 21326936 [TBL] [Abstract][Full Text] [Related]
36. Transposon mutagenesis of Mb0100 at the ppe1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to those of M. bovis BCG. Hotter GS; Wards BJ; Mouat P; Besra GS; Gomes J; Singh M; Bassett S; Kawakami P; Wheeler PR; de Lisle GW; Collins DM J Bacteriol; 2005 Apr; 187(7):2267-77. PubMed ID: 15774869 [TBL] [Abstract][Full Text] [Related]
37. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Pelicic V; Jackson M; Reyrat JM; Jacobs WR; Gicquel B; Guilhot C Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10955-60. PubMed ID: 9380741 [TBL] [Abstract][Full Text] [Related]
38. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine. Wards BJ; de Lisle GW; Collins DM Tuber Lung Dis; 2000; 80(4-5):185-9. PubMed ID: 11052907 [TBL] [Abstract][Full Text] [Related]
40. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG? Martín C Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]